Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers - Denkert, C; von Minckwitz, G; Brase, J C (J Clin Oncol, 2014)
et al.